Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis

Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis

US Patent 5250558 · Granted Oct 5, 1993

Estimated economic value: $22,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aryl sulfone derivatives as calcium channel blockers2012
Biaryl substituted pyrazoles as sodium channel blockers2009
Biaryl substituted triazoles as sodium channel blockers2009
Substituted triazoles as sodium channel blockers2008
Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium ch2008
Biaryl substituted triazoles as sodium channel blockers2008
C1 to C4 side chain modified nodulisporic acid analogs2003
Cloned and expressed human bradykinin BK-2 receptor2002
Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth ho1998
Method for inhibiting activation of the human A3 adenosine receptor to treat ast1998
Phenoxyphenylacetic acid derivatives1998
Muscarine antagonists1998